Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Messing with cancer therapy: how the melanoma phenotype predicts checkpoint inhibitor response.

Signal transduction and targeted therapy - 1 Apr 2024

Meierjohann Svenja, Bertolotto Corine

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Melanoma
Share to Phenotype
Share to Skin Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 38561348
DOI: 10.1038/s41392-024-01785-5
PMCID: PMC10985104

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Messing with cancer therapy: how the melanoma phenotype predicts checkpoint inhibitor response.PMID 38561348Read ↗

Development of Personalized Strategies for Precisely Battling Malignant Melanoma.Semantic proximity Read ↗

Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response RatesSemantic proximity Read ↗

The pathway ahead in melanoma trials.Semantic proximity Read ↗

Recent Progress in Mutation-driven Therapy, Immunotherapy and Combination Therapy for the Treatment of Melanoma.Semantic proximity Read ↗

Driving in the melanoma landscape.Semantic proximity Read ↗

Melanoma genotypes and phenotypes get personal.Semantic proximity Read ↗

Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future PerspectivesSemantic proximity Read ↗

Melanoma researchers have a reason to GRIN: melanoma yields more of its secrets to exome sequencing.Semantic proximity Read ↗

Evolution of Molecular Targets in Melanoma Treatment.Semantic proximity Read ↗

Melanoma as a model for precision medicine in oncology.Semantic proximity Read ↗

Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma.Semantic proximity Read ↗

Pathways and therapeutic targets in melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.